Alexandr B. Guslev
Alexandr B. Guslev has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Andrey Kozaev
Северо-западный государственный медицинский университет имени И.И. Мечникова, Санкт-Петербургская клиническая больница РАН
2 shared publications G M Rutenburg
2 shared publications- I. G. Semenova
Clinical Hospital of the Russian Academy of Sciences
2 shared publications - N. Yu. Semigolovskii
St Petersburg State University
2 shared publications - Sergey O. Mazurenko
Saint Petersburg State University
2 shared publications V V Strizheletskiĭ
2 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 31 (2) , 37-42
Comparative Efficacy and Adherence to Therapy with Duloxetine and Thioctic Acid in Chemotherapy-Induced Neuropathy: Results of a Randomized Study
Background. Despite the positioning of duloxetine as a first-line agent for chemotherapy-induced neuropathy therapy, there are no direct comparative studies of its efficacy versus alternative medications, particularly considering the critically important factor of patient adherence to long-term treatment. Objective. To compare the efficacy of duloxetine and thioctic acid in patients with chemotherapy-induced peripheral neuropathy (CIPN) with emphasis on treatment adherence. Material and methods. A prospective randomized study included 59 patients (26 in the duloxetine group, 33 in the thioctic acid group). Efficacy was assessed using a battery of validated scales: Neurological Disability Score (NDS), Visual Analog Scale for pain (VAS), DN4 questionnaire for verification of neuropathic pain component (Neuropathic Pain Diagnostic Questionnaire, DN4). Safety was recorded according to the principles of Good Clinical Practice (International Council for Harmonisation — Good Clinical Practice, ICH-GCP). Adherence was evaluated by direct patient interviews at 1 month with registration of discontinuation reasons. Results. Analysis of DN4 and NDS scores revealed no statistically significant differences. However, VAS showed a statistically significant difference (p = 0.02): pain increased in the duloxetine group (+ 0.94 ± 2.03 points) and decreased in the thioctic acid group (–0.11 ± 1.32 points). Adherence to duloxetine was 76.9% (20/26) versus 90.9% (30/33) for thioctic acid. Analysis of discontinuation reasons showed that in the duloxetine group, 83.3% of discontinuations were due to adverse effects and 16.7% to psychological barriers related to antidepressant positioning. Adverse effects were registered in 30.8% of duloxetine group patients and 9.1% of thioctic acid group (p = 0.07). Conclusion. Given comparable objective efficacy and more favorable subjective pain dynamics in the thioctic acid group, adherence emerges as the key differentiating factor (76.9% vs 90.9%). The superior safety profile of thioctic acid and absence of psychological barriers make it the drug of first choice for long-term CIPN therapy.
- 17 June 2026
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 31 (2) , 37-42
Open AccessComparative Efficacy and Adherence to Therapy with Duloxetine and Thioctic Acid in Chemotherapy-Induced Neuropathy: Results of a Randomized Study
Background. Despite the positioning of duloxetine as a first-line agent for chemotherapy-induced neuropathy therapy, there are no direct comparative studies of its efficacy versus alternative medications, particularly considering the critically important factor of patient adherence to long-term treatment. Objective. To compare the efficacy of duloxetine and thioctic acid in patients with chemotherapy-induced peripheral neuropathy (CIPN) with emphasis on treatment adherence. Material and methods. A prospective randomized study included 59 patients (26 in the duloxetine group, 33 in the thioctic acid group). Efficacy was assessed using a battery of validated scales: Neurological Disability Score (NDS), Visual Analog Scale for pain (VAS), DN4 questionnaire for verification of neuropathic pain component (Neuropathic Pain Diagnostic Questionnaire, DN4). Safety was recorded according to the principles of Good Clinical Practice (International Council for Harmonisation — Good Clinical Practice, ICH-GCP). Adherence was evaluated by direct patient interviews at 1 month with registration of discontinuation reasons. Results. Analysis of DN4 and NDS scores revealed no statistically significant differences. However, VAS showed a statistically significant difference (p = 0.02): pain increased in the duloxetine group (+ 0.94 ± 2.03 points) and decreased in the thioctic acid group (–0.11 ± 1.32 points). Adherence to duloxetine was 76.9% (20/26) versus 90.9% (30/33) for thioctic acid. Analysis of discontinuation reasons showed that in the duloxetine group, 83.3% of discontinuations were due to adverse effects and 16.7% to psychological barriers related to antidepressant positioning. Adverse effects were registered in 30.8% of duloxetine group patients and 9.1% of thioctic acid group (p = 0.07). Conclusion. Given comparable objective efficacy and more favorable subjective pain dynamics in the thioctic acid group, adherence emerges as the key differentiating factor (76.9% vs 90.9%). The superior safety profile of thioctic acid and absence of psychological barriers make it the drug of first choice for long-term CIPN therapy.
- 20 November 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 16,p. 61-68
Cardioprotection method for percutaneous coronary interventions in elderly patients with acute coronary syndrome
Introduction . Acute coronary syndrome (ACS) is the main cause of death in elderly patients who suffer worse from percutaneous coronary interventions (PCI), and new cardioprotection techniques are in high demand. Aim . To study the efficacy of levocarnitine in preventing complications due to PCI in elderly patients with acute coronary syndrome. Materials and methods . 80 ACS patients were randomized into 2 groups of 40 people: the main group was the average age of 78 (75, 93), received 1.0 g of levocarnitine intracoronary, followed by an intravenous infusion of 2.0 g/day for 3 days; and the control group of age 77 (75, 91) received placebo administration. PCI was performed an average of 3.5 hours after the onset of ACS symptoms. The MB fraction of creatine phosphokinase (CPK-MV) and highly sensitive troponin I (hsTrI), ECG and EchoCG parameters in dynamics, course and outcomes were determined. Results . The dynamics of biomarker levels was more favorable in the main group, where there was a smaller increase in hsTrI at 1 day after PCI and an accelerated decrease at 3 day after PCI. CPK-MB on day 3 in the main group was significantly lower than the control level (p < 0.001). The significantly lower average left ventricular ejection fraction in the main group initially (p < 0.023) significantly exceeded the control level on day 3 after PCI (p < 0.001). There was a faster positive dynamics of the ECG and a tendency to decrease the frequency of arrhythmic episodes in the main group compared with the control group. There was no hospital mortality in the main group, and it was 10.0% in the control group. Conclusions . The described technique of adjuvant cardioprotection in PCI appears to be an available, effective and safe addition to the standard provision of reperfusion in elderly patients with ACS.
- 20 November 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 16,p. 61-68
Cardioprotection method for percutaneous coronary interventions in elderly patients with acute coronary syndrome
Introduction . Acute coronary syndrome (ACS) is the main cause of death in elderly patients who suffer worse from percutaneous coronary interventions (PCI), and new cardioprotection techniques are in high demand. Aim . To study the efficacy of levocarnitine in preventing complications due to PCI in elderly patients with acute coronary syndrome. Materials and methods . 80 ACS patients were randomized into 2 groups of 40 people: the main group was the average age of 78 (75, 93), received 1.0 g of levocarnitine intracoronary, followed by an intravenous infusion of 2.0 g/day for 3 days; and the control group of age 77 (75, 91) received placebo administration. PCI was performed an average of 3.5 hours after the onset of ACS symptoms. The MB fraction of creatine phosphokinase (CPK-MV) and highly sensitive troponin I (hsTrI), ECG and EchoCG parameters in dynamics, course and outcomes were determined. Results . The dynamics of biomarker levels was more favorable in the main group, where there was a smaller increase in hsTrI at 1 day after PCI and an accelerated decrease at 3 day after PCI. CPK-MB on day 3 in the main group was significantly lower than the control level (p < 0.001). The significantly lower average left ventricular ejection fraction in the main group initially (p < 0.023) significantly exceeded the control level on day 3 after PCI (p < 0.001). There was a faster positive dynamics of the ECG and a tendency to decrease the frequency of arrhythmic episodes in the main group compared with the control group. There was no hospital mortality in the main group, and it was 10.0% in the control group. Conclusions . The described technique of adjuvant cardioprotection in PCI appears to be an available, effective and safe addition to the standard provision of reperfusion in elderly patients with ACS.
- Open Access
- 18 January 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 23,p. 50-59
Cardioprotection with levocarnitine intracoronary administration during percutaneous coronary interventions
Currently, the number of percutaneous coronary interventions (PCI) performed in acute and chronic forms of coronary heart disease continues to grow: every year their number reaches at least 5,000,000 worldwide, and more than 200,000 of them in Russia. The main causes of postoperative mortality are perioperative myocardial infarction and acute heart failure due to inadequate protection of the myocardium from ischemia/reperfusion under conditions of balloon expansion and stenting of the affected coronary arteries. The review presents experimental and clinical literature data on the successful use of levocarnitine for cardioprotection in patients with various forms of coronary heart disease and patients with chronic heart failure, both with intravenous administration and as part of a cardioplegic solution during heart surgery. The intracoronary route of administration of levocarnitine solution during PCI in high-risk patients (elderly and senile patients, with multivessel lesions of the coronary bed, difficulties in conducting the intervention) is substantiated. The description of two clinical cases of the use of the technique in elderly patients with acute forms of coronary heart disease with multivessel lesion is given. The postoperative period proceeded without complications with smooth dynamics of biomarkers (troponin I, total creatinephosphokinase, MB-fraction of creatinephosphokinase, lactate dehydrogenase), ischemic ECG shifts were little pronounced. The expected results of the application of the technique are a reduction in intraoperative and postoperative complications of ischemia/ reperfusion and an increase in the effectiveness of the clinical results of PCI in high-risk patients.
- 18 January 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 23,p. 50-59
Open AccessCardioprotection with levocarnitine intracoronary administration during percutaneous coronary interventions
Currently, the number of percutaneous coronary interventions (PCI) performed in acute and chronic forms of coronary heart disease continues to grow: every year their number reaches at least 5,000,000 worldwide, and more than 200,000 of them in Russia. The main causes of postoperative mortality are perioperative myocardial infarction and acute heart failure due to inadequate protection of the myocardium from ischemia/reperfusion under conditions of balloon expansion and stenting of the affected coronary arteries. The review presents experimental and clinical literature data on the successful use of levocarnitine for cardioprotection in patients with various forms of coronary heart disease and patients with chronic heart failure, both with intravenous administration and as part of a cardioplegic solution during heart surgery. The intracoronary route of administration of levocarnitine solution during PCI in high-risk patients (elderly and senile patients, with multivessel lesions of the coronary bed, difficulties in conducting the intervention) is substantiated. The description of two clinical cases of the use of the technique in elderly patients with acute forms of coronary heart disease with multivessel lesion is given. The postoperative period proceeded without complications with smooth dynamics of biomarkers (troponin I, total creatinephosphokinase, MB-fraction of creatinephosphokinase, lactate dehydrogenase), ischemic ECG shifts were little pronounced. The expected results of the application of the technique are a reduction in intraoperative and postoperative complications of ischemia/ reperfusion and an increase in the effectiveness of the clinical results of PCI in high-risk patients.
- Open Access
- 9 January 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (1) , 135
Specific Features of Juvenile Idiopathic Arthritis Patients’ Cytokine Profile
Juvenile idiopathic arthritis (JIA) is a systemic autoimmune disease that affects the joints, leading to disability. Cytokines and signaling molecules expressed by the immune system cells play a key role in JIA pathogenesis. Understanding how their content changes during pathology development can open up new opportunities for its diagnosis and treatment. The blood plasma of 30 patients with JIA (14 males and 16 females with a mean age of 12.2 ± 4.1) and 20 relatively healthy individuals (10 males and 10 females with a mean age of 10.20 ± 5.85) was analyzed to determine the levels of cytokines using the MILLIPLEX® kit. An increase in interleukins (IL)-1α, 1β, 2, 4, 5, 6, 7, 8, 9, 10, 13, 15, 17F, 22, and 27 and a decrease in IL-3 levels have been shown in patients with JIA. Levels of cytokines, which are important for B-cell activation and proliferation, are increased, while levels of T-cell activating factors remained similar to the control group. Based on our results, it can be assumed that the use of combination therapy aimed at inhibiting both nonspecific interleukins and cytokines that activate B-cells will be more effective for the treatment of JIA.
- 9 January 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (1) , 135
Open AccessSpecific Features of Juvenile Idiopathic Arthritis Patients’ Cytokine Profile
Juvenile idiopathic arthritis (JIA) is a systemic autoimmune disease that affects the joints, leading to disability. Cytokines and signaling molecules expressed by the immune system cells play a key role in JIA pathogenesis. Understanding how their content changes during pathology development can open up new opportunities for its diagnosis and treatment. The blood plasma of 30 patients with JIA (14 males and 16 females with a mean age of 12.2 ± 4.1) and 20 relatively healthy individuals (10 males and 10 females with a mean age of 10.20 ± 5.85) was analyzed to determine the levels of cytokines using the MILLIPLEX® kit. An increase in interleukins (IL)-1α, 1β, 2, 4, 5, 6, 7, 8, 9, 10, 13, 15, 17F, 22, and 27 and a decrease in IL-3 levels have been shown in patients with JIA. Levels of cytokines, which are important for B-cell activation and proliferation, are increased, while levels of T-cell activating factors remained similar to the control group. Based on our results, it can be assumed that the use of combination therapy aimed at inhibiting both nonspecific interleukins and cytokines that activate B-cells will be more effective for the treatment of JIA.
- Open Access
- 29 March 2022
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 9 (2) , 107-112
Prospects of the vacuum aspiration biopsy in terms of making the diagnoosis of malignant neoplasms of the mammary glands in patients categorised 3 and 4 according to BIRADS scale
Purpose of the study. Was to assess the prospects for the use of vacuum aspiration biopsy in terms of breast cancer diagnosis in patients with focal breast changes categorised by 3 and 4a according to the BIRADS scale.Materials and methods. In the period from February 2020 to July 2021, 41 (n = 41) the patient with nodules of 3 and 4a categories according to BIRADS has been passed 41 vacuum aspiration biopsies (VAB) (n = 41) under local infiltration anesthesia with ultrasound navigation. The 17 % (n = 7) of the nodular neoplasms were represented by multiple lesions. The ultrasound examination was mandatory for all the patients and the 17 % (n = 7) was combined with mammography. Invasive diagnostics of tissue material from tumors subject to VAB was previously performed in 5 patients. Trephine biopsy was also performed in 4 cases and the fine needle aspiration biopsy (TAB) was performed in 1 case. Tissue atypia was not detected in all cases.Results. The removed lesions were benign in 85.3 % (n = 35) of the cases. Breast cancer was diagnosed in 4.8 % of cases (n = 2), cancer in situ was diagnosed in 9.7 % (n = 4). The cases of invasive cancer were observed in both BIRADS categories, while in situ cancer was diagnosed in only 4a BIRADS categories. The residual tissue of the formation was detected in 1 case (n = 1). During the procedure, no complications were revealed. Moreover, in the early postoperative period, seroma formation has occurred in 2 patients 4.8 % (n = 2). All the patients noted the satisfactory tolerance to the manipulation.Conclusion. The data obtained suggest that vacuum aspiration biopsy has a high diagnostic accuracy and certain advantages in this category of patients, in particular cases of urgent need to conduct more precise invasive diagnostics without performing the excisional biopsy examination.
- 29 March 2022
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 9 (2) , 107-112
Open AccessProspects of the vacuum aspiration biopsy in terms of making the diagnoosis of malignant neoplasms of the mammary glands in patients categorised 3 and 4 according to BIRADS scale
Purpose of the study. Was to assess the prospects for the use of vacuum aspiration biopsy in terms of breast cancer diagnosis in patients with focal breast changes categorised by 3 and 4a according to the BIRADS scale.Materials and methods. In the period from February 2020 to July 2021, 41 (n = 41) the patient with nodules of 3 and 4a categories according to BIRADS has been passed 41 vacuum aspiration biopsies (VAB) (n = 41) under local infiltration anesthesia with ultrasound navigation. The 17 % (n = 7) of the nodular neoplasms were represented by multiple lesions. The ultrasound examination was mandatory for all the patients and the 17 % (n = 7) was combined with mammography. Invasive diagnostics of tissue material from tumors subject to VAB was previously performed in 5 patients. Trephine biopsy was also performed in 4 cases and the fine needle aspiration biopsy (TAB) was performed in 1 case. Tissue atypia was not detected in all cases.Results. The removed lesions were benign in 85.3 % (n = 35) of the cases. Breast cancer was diagnosed in 4.8 % of cases (n = 2), cancer in situ was diagnosed in 9.7 % (n = 4). The cases of invasive cancer were observed in both BIRADS categories, while in situ cancer was diagnosed in only 4a BIRADS categories. The residual tissue of the formation was detected in 1 case (n = 1). During the procedure, no complications were revealed. Moreover, in the early postoperative period, seroma formation has occurred in 2 patients 4.8 % (n = 2). All the patients noted the satisfactory tolerance to the manipulation.Conclusion. The data obtained suggest that vacuum aspiration biopsy has a high diagnostic accuracy and certain advantages in this category of patients, in particular cases of urgent need to conduct more precise invasive diagnostics without performing the excisional biopsy examination.
- Open Access
- 2 May 2020
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 179 (1) , 46-50
Laparoscopic surgery for recurrent inguinal hernias
Лапароскопические вмешательства при рецидивных паховых грыжах
- 2 May 2020
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 179 (1) , 46-50
Open AccessLaparoscopic surgery for recurrent inguinal hernias
Лапароскопические вмешательства при рецидивных паховых грыжах
- Open Access
- 25 July 2018
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 7 (2) , 152-155
THE TACTICS OF SURGICAL TREATMENT FOR GASTRIC BLEEDING TUMORS IN ELDERLY AND SENILE PATIENTS
The results of treatment of 112 patients of elderly and senile age patients with non-metastatic gastric cancer, complicated by bleeding were analyzed. Most often bleedings occurred for stomach cancer stage III−IV. The tumor was commonly located in the gastric body. The vast majority of patients had only one complication — bleeding. In the second (control) group, there was no unified diagnostic and treatment algorithm, patients were usually operated urgently upon admission or in case of recurrent bleeding. The differential diagnostic and treatment algorithm was developed for patients of group I (main) taking into account the condition of a patient and the severity of bleeding or repeated bleeding. In the control group, the indications for emergency surgery were continued bleeding and inefficiency of endoscopic hemostasis. In the main group, the risk of recurrent bleeding was considered as well, and in case of high risk emergency surgery was performed after a full preoperative preparation. In addition, the cardial part or 2/3 of the stomach were not resected by reason of the deliberate non-radical tactics. It is worth noting that in the I group argon plasma coagulation, complemented by the hemostatic system EndoClot was used for endoscopic hemostasis. Through the use of the developed algorithm we managed to reliably reduce the frequency of complications from 50 to 28.5% (p<0.05), and mortality rate from 28.8 to 3.77% (p<0.001).
- 25 July 2018
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 7 (2) , 152-155
Open AccessTHE TACTICS OF SURGICAL TREATMENT FOR GASTRIC BLEEDING TUMORS IN ELDERLY AND SENILE PATIENTS
The results of treatment of 112 patients of elderly and senile age patients with non-metastatic gastric cancer, complicated by bleeding were analyzed. Most often bleedings occurred for stomach cancer stage III−IV. The tumor was commonly located in the gastric body. The vast majority of patients had only one complication — bleeding. In the second (control) group, there was no unified diagnostic and treatment algorithm, patients were usually operated urgently upon admission or in case of recurrent bleeding. The differential diagnostic and treatment algorithm was developed for patients of group I (main) taking into account the condition of a patient and the severity of bleeding or repeated bleeding. In the control group, the indications for emergency surgery were continued bleeding and inefficiency of endoscopic hemostasis. In the main group, the risk of recurrent bleeding was considered as well, and in case of high risk emergency surgery was performed after a full preoperative preparation. In addition, the cardial part or 2/3 of the stomach were not resected by reason of the deliberate non-radical tactics. It is worth noting that in the I group argon plasma coagulation, complemented by the hemostatic system EndoClot was used for endoscopic hemostasis. Through the use of the developed algorithm we managed to reliably reduce the frequency of complications from 50 to 28.5% (p<0.05), and mortality rate from 28.8 to 3.77% (p<0.001).
- 18 March 2009
- Published by ROSOMED in Virtual Technologies in Medicine
- No. 1,p. 4-6
Первый опыт использования виртуальных тренажеров
Virtual Simulator, of course, does not replace the traditional forms of education - lecture course, video and multimedia materials, surgery assistance , etc., however, physician has to train his practical skills prior to admission to patient.
- 18 March 2009
- Published by ROSOMED in Virtual Technologies in Medicine
- No. 1,p. 4-6
Первый опыт использования виртуальных тренажеров
Virtual Simulator, of course, does not replace the traditional forms of education - lecture course, video and multimedia materials, surgery assistance , etc., however, physician has to train his practical skills prior to admission to patient.
- 1 January 2006
- Vol. 165 (6) , 15-20
[The place of endovideosurgical interventions in treatment of inguinal hernias].
Endovideosurgical hernioplasty was performed in 3020 patients. Complex forms of inguinal hernias were diagnosed in 280 of them. These forms included: bilateral and combined inguinal hernias, inguinoscrotal hernias, sliding hernias, fixed and irreducible inguinal hernias, recurrent inguinal hernias after traditional herniorrhaphy and recurrent hernias after endovideosurgical hernioplasty. Original technical maneuvers are described, indications and contraindications were established, complications and results of treatment of patients with inguinal hernias were analyzed and evaluated. Recommendations are given for the treatment of patients with complex forms of hernias.
- 1 January 2006
- Vol. 165 (6) , 15-20
[The place of endovideosurgical interventions in treatment of inguinal hernias].
Endovideosurgical hernioplasty was performed in 3020 patients. Complex forms of inguinal hernias were diagnosed in 280 of them. These forms included: bilateral and combined inguinal hernias, inguinoscrotal hernias, sliding hernias, fixed and irreducible inguinal hernias, recurrent inguinal hernias after traditional herniorrhaphy and recurrent hernias after endovideosurgical hernioplasty. Original technical maneuvers are described, indications and contraindications were established, complications and results of treatment of patients with inguinal hernias were analyzed and evaluated. Recommendations are given for the treatment of patients with complex forms of hernias.
- 1 January 1995
- No. 5,p. 27-9
[Immediate results of laparoscopic hernioplasty in inguinal and femoral hernias].
In 1992-1994 laparoscopic hernioplasty was performed in 403 patients with inguinal (371) and femoral (32) hernias. Mean duration of hospital-stay 2.3 days, period of incapacity 9.7 days. Complication were encountered in 25 (3.7%) patients, including perforation of the small intestine and commissural ileus for which laparotomy had to be performed. Recurrent hernias occurred in 7 (1.7%) patients in periods of 2 weeks to 1.5 month due to poor fixation of the implant and choice of an inadequate operative method.
- 1 January 1995
- No. 5,p. 27-9
[Immediate results of laparoscopic hernioplasty in inguinal and femoral hernias].
In 1992-1994 laparoscopic hernioplasty was performed in 403 patients with inguinal (371) and femoral (32) hernias. Mean duration of hospital-stay 2.3 days, period of incapacity 9.7 days. Complication were encountered in 25 (3.7%) patients, including perforation of the small intestine and commissural ileus for which laparotomy had to be performed. Recurrent hernias occurred in 7 (1.7%) patients in periods of 2 weeks to 1.5 month due to poor fixation of the implant and choice of an inadequate operative method.